How is the cumulative pregnancy rate in in vitro fertilization (IVF) calculated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calculation of Cumulative Pregnancy Rate in IVF

Cumulative pregnancy rate in IVF is calculated using life-table analysis with the number of pregnancies achieved as the numerator and the number of patients who started treatment (per course of treatment started) as the denominator, tracking outcomes across multiple fresh and frozen embryo transfer cycles from a single or multiple stimulation cycles. 1

Standard Calculation Method

The most appropriate denominator is "per course of treatment started" rather than per transfer or per oocyte retrieval, as this provides the most realistic assessment of success for patients deciding whether to undertake IVF treatment. 1

Key Components of the Calculation:

  • Numerator: Total number of pregnancies (clinical, ongoing, or live births depending on the outcome measured) achieved across all cycles 1

  • Denominator: All patients who initiated treatment, regardless of whether they completed all planned cycles 1

  • Time frame: Cumulative rates track outcomes across multiple treatment cycles (typically 3-6 cycles) within a defined period 2, 3, 4

Methodological Considerations

Handling Patient Drop-Out

Three approaches exist for managing patients who discontinue treatment, with the third method providing the most realistic estimates: 2

  • Method 1 (underestimates): Assumes patients who stopped treatment have zero chance of pregnancy 2

  • Method 2 (overestimates): Assumes patients who stopped have the same pregnancy probability as those who continued—this is the most commonly used but inflates success rates 2, 5

  • Method 3 (most realistic): Assumes only patients who stopped for medical reasons have zero pregnancy chance, while others who stopped for non-medical reasons have the same probability as those who continued 2

Critical Pitfall: Denominator Selection

A major methodological error occurs when researchers use subgroups (per transfer or per oocyte retrieval) rather than the randomized cohort as the denominator. This undermines the validity of randomized trials because it disrupts the balance of confounding factors established by randomization. 1, 6

  • Studies using "per transfer" denominators exclude a median of 8% (range 2-38%) of participants, potentially biasing results 1

  • The correct approach defines patients who fail to reach embryo transfer as having an unsuccessful treatment response 1

Reporting Standards

Outcome-Specific Denominators

According to the 2016 Human Reproduction Update systematic review of IVF RCTs: 1

  • Cumulative clinical pregnancy: Should be reported per course of treatment started (only 1% of studies did this correctly) 1

  • Cumulative ongoing pregnancy: Should be reported per course of treatment started (only 2% of studies did this correctly) 1

  • Cumulative live birth: Should be reported per cycle started (only 3-5% of studies reported this cumulatively across multiple fresh and frozen transfers) 1

Proper Statistical Approach

Life-table analysis is the standard statistical method for calculating cumulative pregnancy rates, allowing for censoring of patients who discontinue treatment at different time points. 2, 5, 7, 4

  • The Cox proportional hazards model can estimate the influence of covariates (age, diagnosis, etc.) on cumulative success 7

  • Cumulative rates should account for both fresh and frozen embryo transfers from the same stimulation cycle 1

Expected Cumulative Rates

Research demonstrates that cumulative pregnancy rates increase substantially with multiple cycles: 7, 3, 4

  • After 3 cycles: Clinical pregnancy rates of 54-57%, live birth rates of 48-51% 3

  • After 6 cycles: Pregnancy rates approaching 55-60% 7, 4

  • Age-dependent decline: Cumulative rates decline significantly with increasing maternal age 3

Common Errors to Avoid

Never report cumulative pregnancy rates per embryo transferred—embryos are not statistically independent units, and outcomes are defined at the patient level. 1, 6

Never exclude patients who failed to reach certain treatment stages (oocyte retrieval, embryo transfer) from the denominator, as this violates intention-to-treat principles and creates selection bias. 1

Never use a single outcome measure without pre-specification, as reporting multiple outcomes increases the risk of false discoveries through multiple testing. 1, 6

Related Questions

As a 22‑year‑old, how can I obtain a Do‑Not‑Resuscitate (DNR) order and what are the eligibility criteria?
In a 19‑year‑old female with a three‑month history of progressive right‑temporal headache aggravated by coughing, cold exposure, bright light, and fan airflow, now accompanied by right‑sided painful ophthalmoplegia (intermittent diplopia that resolves when one eye is covered, medial deviation of the right eye, right upper‑eyelid ptosis, and retro‑orbital pain) and no fever or other systemic signs, what is the most likely diagnosis and what urgent investigations and initial management are recommended?
What is the appropriate evaluation and initial management for a 19‑year‑old male with severe unexplained weight loss?
In a 21-year-old female runner who developed leg pain and progressively spreading bruising, what urgent evaluation and management are indicated?
What is the appropriate management for a 34-year-old male presenting with a blood pressure of 200/160 mm Hg?
When can treadmill walking be resumed after uncomplicated cataract surgery?
Does a female patient with short stature, delayed puberty, primary amenorrhea, streak gonads, webbed neck, and low posterior hairline have Turner syndrome?
For a 52‑year‑old female with sinus problems, depression and anxiety currently on sertraline 50 mg and buspirone, can I safely switch to escitalopram and increase the buspirone dose, and what are the recommended dosing and monitoring guidelines?
What is the best medication for treating ADHD in a patient with bipolar disorder?
Can age‑related macular degeneration be asymptomatic?
Is a black foot more concerning for a venous versus arterial etiology?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.